Market Overview

15 Biggest Mid-Day Losers For Wednesday

Related XOMA
XOMA Challenged With A 'Major Financing Overhang'
7 Stocks That Rallied Four Days, Then Sold Off Yesterday
Credit Suisse Says Gr3 Diarrhea Still A Concern For Puma Biotech, But Pullback Is Overdone
Puma Biotech Crashes After Bad News About Its Breast Cancer Drug
Puma Cancer Drug Suffers 'Approvability Risk' On Extreme Side Effect (Investor's Business Daily)


  • XOMA Corp (NASDAQ: XOMA) shares fell 18.3 percent to $5.10 after the company disclosed a significant step toward initiating pediatric Phase 2 clinical study for XOMA 358 in children with congenital hyperinsulinism.
  • Puma Biotechnology Inc (NYSE: PBYI) dropped 15.4 percent to $44.55 after the company announced a $150 million offering of common stock.
  • Imperva Inc (NYSE: IMPV) shares fell 14.4 percent to $39.95 after concerns were raised on the possible sale. According to a Bloomberg report, the sale process has been put on a hold, as the company is seeking increased deal price.
  • VASCO Data Security International, Inc. (NASDAQ: VDSI) shares tumbled 14 percent to $15.43 as the company lowered its FY16 revenue guidance. Dougherty & Co. downgraded VASCO Data Security from Buy to Neutral.
  • Acadia Healthcare Company Inc (NASDAQ: ACHC) shares fell 11.4 percent to $40.04 after the company reported the signing of definitive deal for sale of UK facilities in fulfillment of previously announced undertakings to the CMA. The company issued a weak forecast for the third quarter.
  • WSI Industries, Inc. (NASDAQ: WSCI) shares slipped 11.3 percent to $3.27. WSI Industries reported a Q4 loss of $0.01 per share on sales of $8.1 million.
  • Cree, Inc. (NASDAQ: CREE) shares declined 10.8 percent to $22.48 after the company issued a weak earnings forecast for the fiscal second quarter.
  • UniFirst Corp (NYSE: UNF) fell 10 percent to $117.80. Unifirst reported Q4 earnings of $1.74 per share on revenue of $363 million.
  • Manhattan Associates, Inc. (NASDAQ: MANH) declined 8.6 percent to $53.94. Manhattan Associates reported Q3 earnings of $0.50 per share on revenue of $152.2 million. The company also raised its FY16 earnings guidance.
  • Sangamo Biosciences, Inc. (NASDAQ: SGMO) shares dropped 8.5 percent to $3.57 after gaining 1.30 percent on Tuesday.
  • SUPERVALU INC. (NYSE: SVU) shares declined 8.3 percent to $4.61. SUPERVALU reported in-line quarterly earnings, but missed sales estimates.
  • Intel Corporation (NASDAQ: INTC) shares slipped 5.8 percent to $35.57. Intel reported better-than-expected earnings for its third quarter, but issued a weak revenue forecast for the current quarter.
  • Meridian Bioscience, Inc. (NASDAQ: VIVO) shares fell 5.6 percent to $17.60 after the company issued a weak outlook.
  • Nektar Therapeutics (NASDAQ: NKTR) shares declined 5 percent to $13.36 after dropping 10.15 percent on Tuesday.
  • Ascendis Pharma A/S (NASDAQ: ASND) shares slipped 3.7 percent to $19.34. Ascendis Pharma priced its 6.3 million share offering at $19 per ADS.

Posted-In: Mid-Day LosersNews Movers & Shakers Intraday Update Markets


Related Articles (ACHC + ASND)

View Comments and Join the Discussion!